AscellaHealth’s Q2 2024 Specialty & Rare Pipeline Digest™ Shows Rising Specialty Pharmaceuticals Demand
AscellaHealth, a global partner specializing in end-to-end solutions for life sciences and healthcare companies aimed at improving the quality of life for patients with complex, chronic conditions, has launched its latest edition of the Specialty & Rare Pipeline Digest™. This…
Vabysmo by Genentech Demonstrates Long-Term Effectiveness and Safety in Diabetic Macular Edema Study
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), unveiled new four-year findings from the RHONE-X extension study today. The study successfully met all primary endpoints, underscoring the well-tolerated nature of Vabysmo® (faricimab-svoa) in individuals with diabetic…
Lynch Regenerative Medicine Concludes Series A Funding Round
Lynch Regenerative Medicine, LLC (LRM) has successfully concluded its Series A financing to advance innovative skin rejuvenation and regeneration solutions based on FDA-approved pure platelet-derived growth factor (PDGF). Champion VC, managing assets of the Frist family of Nashville, Tennessee, led…
CytoReason Raises $80M to Expand AI Disease Models, Launch US Hub
CytoReason, a pioneer in computational disease models for predictive insights, has secured $80 million from OurCrowd, NVIDIA (Nasdaq: NVDA), Pfizer (NYSE: PFE), and Thermo Fisher Scientific (NYSE: TMO). “This investment underscores the potential of computational disease models to revolutionize data…
MedImpact Successfully Integrates Elixir Solutions
MedImpact Healthcare Systems, Inc., the nation’s largest independent provider of health solutions, technology, and pharmacy benefit management services, has announced the successful completion of the integration of Elixir Solutions. This strategic acquisition not only enhances MedImpact’s scale and expands its…
Novocuff secures $26M to advance tech combating preterm births.
Novocuff, Inc., a medical device company focused on enhancing pregnancy outcomes and minimizing the risk of preterm birth, has successfully concluded an oversubscribed $26 million Series A funding round following an initial $2 million seed round. AXA IM Alts led…
Galvani Bioelectronics Advances Therapy Platform, Appoints New Chief Medical Officer
Galvani Bioelectronics, a clinical-stage therapeutics company resulting from a partnership between GSK and Verily Life Sciences, has initiated recruitment for the randomized, controlled phase of a clinical feasibility study targeting patients with Rheumatoid Arthritis (RA). This advancement follows FDA approval,…
Study Finds No Survival Difference Between Mismatched and Matched Unrelated Donors
Research findings published today in the peer-reviewed Journal of Clinical Oncology by NMDP℠ and CIBMTR® (Center for International Blood and Marrow Transplant Research®) indicate that there is no significant difference in overall survival (OS) for patients with blood cancer undergoing…
Sensorion Reports Positive Secondary Endpoints in SENS-401 Phase 2a Trial for Hearing Loss Preservation
Sensorion (FR0012596468 – ALSEN), a pioneering biotechnology company specializing in hearing loss disorders, has unveiled new positive findings from its SENS-401 Phase 2a clinical trial. The data, focusing on the preservation of residual hearing following cochlear implantation in adult patients,…
Diakonos Oncology: FDA Fast Track for Pancreatic Cancer Vaccine; Adds Dr. Daniel D. Von Hoff to Advisory Board
Diakonos Oncology Corporation (“Diakonos”), a pioneer in immuno-oncology, announced today that its dendritic cell vaccine (DCV) for pancreatic ductal adenocarcinoma has received Fast Track designation from the U.S. Food and Drug Administration (FDA). This recognition highlights the potential of Diakonos’…
Teladoc Health Offers Free Virtual Care for Hurricane Beryl-Affected Texans
Teladoc Health (NYSE: TDOC), a global leader in comprehensive virtual care, is providing complimentary 24/7 general medical telehealth consultations to Texas residents, first responders, and others directly impacted by Hurricane Beryl. Texas individuals displaced or unable to access traditional medical…
Karthik Rao, M.D., Named Chief Medical Officer of Agilon Health
Agilon Health, Inc. (NYSE: AGL), a leader in empowering physicians to innovate healthcare delivery, announced today the appointment of Dr. Karthik Rao as permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao, who has been serving as agilon’s interim CMO…